In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine

被引：0
|
作者：
Anand Joshi
Brian F. Kiesel
Nupur Chaphekar
Reyna Jones
Jianxia Guo
Charles A. Kunos
Sarah Taylor
Edward Chu
Raman Venkataramanan
Jan H. Beumer
机构：
[1] University of Pittsburgh,Department of Pharmaceutical Sciences, School of Pharmacy
[2] UPMC Hillman Cancer Center,Cancer Therapeutics Program
[3] National Cancer Institute,Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis
[4] University of Pittsburgh-Magee Women’s Hospital,Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Medicine
[5] University of Pittsburgh School of Medicine,Division of Hematology
[6] University of Pittsburgh,Oncology, Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词：
Triapine; Metabolism; Drug–drug interaction; CYP450; Metabolic pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：633 / 640
页数：7
相关论文
共 50 条
  • [41] An evaluation of the potential drug interaction between warfarin and levothyroxine
    Wood, M. D.
    Delate, T.
    Clark, M.
    Clark, N.
    Horn, J. R.
    Witt, D. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (08) : 1313 - 1319
  • [42] Evaluation Of CYP450 and Transporter-Mediated Drug-Drug Interaction Potential Of Pomalidomide In Healthy Men and In Vitro
    Kasserra, Claudia
    Assaf, Mahmoud
    Hoffmann, Matthew
    Li, Yan
    Liu, Liangang
    Wang, Xiaomin
    Kumar, Gondi
    Palmisano, Maria
    BLOOD, 2013, 122 (21)
  • [43] In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies
    Wang, Lifei
    Zhang, Donglu
    Raghavan, Nirmala
    Yao, Ming
    Ma, Li
    Frost, Charles A.
    Maxwell, Brad D.
    Chen, Shiang-yuan
    He, Kan
    Goosen, Theunis C.
    Humphreys, W. Griffith
    Grossman, Scott J.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (03) : 448 - 458
  • [44] In vitro assessment of the roles of drug transporters in the disposition and drug-drug interaction potential of olaparib
    McCormick, Alex
    Swaisland, Helen
    XENOBIOTICA, 2017, 47 (10) : 903 - 915
  • [45] Evaluation of in-vitro drug drug interaction data using PBPK models
    Freidig, AP
    Bogaards, JPP
    Bouzom, F
    Jochemsen, R
    Vermeulen, NPE
    DRUG METABOLISM REVIEWS, 2003, 35 : 22 - 22
  • [46] AN IN VITRO SCREENING METHOD TO EVALUATE THE DRUG-DRUG INTERACTION DUE TO INHIBITION OF SULFOTRANSFERASE ENZYMES (SULTS)
    Taimi, Mohammed
    Gilbert, Jon
    DRUG METABOLISM REVIEWS, 2014, 45 : 167 - 167
  • [47] Role of in vitro metabolic interactions in the conduct of drug-drug interaction (DDI) studies.
    Yuan, R
    Balian, JD
    Svadjian, R
    Uppoor, RS
    Ajayi, F
    Burnett, A
    Lesko, LJ
    Marroum, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 218 - 218
  • [48] Drug metabolic enzymes in developmental toxicology
    Miller, MS
    Juchau, MR
    Guengerich, FP
    Nebert, DW
    Raucy, JL
    FUNDAMENTAL AND APPLIED TOXICOLOGY, 1996, 34 (02): : 165 - 175
  • [49] Herb-drug interaction potential of Astragali Radix: a metabolic perspective
    Wang, Tianwang
    Chen, Xiaofei
    Gao, Qing
    Huang, Chonggang
    Wang, Kai
    Qiu, Feng
    DRUG METABOLISM REVIEWS, 2025, 57 (01) : 9 - 25
  • [50] RITONAVIR INHIBITS PRASUGREL IN VITRO BIOACTIVATION: A POTENTIAL PHARMACOKINETIC DRUG-DRUG INTERACTION
    Ancrenaz, V.
    Daali, Y.
    Samer, C.
    Dayer, P.
    Desmeules, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S56 - S56
12345